Movement Disorders (revue) - Exploration (Accueil)

Index « Keywords » - entrée « Dopamine Antagonists (adverse effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dopamine Antagonists (administration & dosage) < Dopamine Antagonists (adverse effects) < Dopamine Antagonists (diagnostic use)  Facettes :

List of bibliographic references indexed by Dopamine Antagonists (adverse effects)

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000531 (2014) Subhashie Wijemanne [États-Unis] ; Laura J C. Wu ; Joseph Jankovic [États-Unis]Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome.
002092 (2009) Susanne A. Schneider [Royaume-Uni] ; Vrajesh Udani [Inde] ; Charulata Sawant Sankhla [Inde] ; Kailash P. Bhatia [Royaume-Uni]Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs
002231 (2009) Han-Joon Kim [Corée du Sud] ; Joong-Yang Cho [Corée du Sud] ; Yong-Jin Cho [Corée du Sud] ; Keun-Sik Hong [Corée du Sud]Levosulpiride‐induced resting orolingual tremor
003344 (2006) Devi Nampiaparampil [États-Unis] ; Nimet E. Oruc [États-Unis]Metodopramide‐induced palatopharyngeal myoclonus
003446 (2006) Mazen Jabre [Liban] ; Boulos-Paul Bejjani [Liban]Etiological and therapeutical observations in a case of belly dancer's dyskinesia
004B09 (2000) David Devos [France] ; Luc Defebvre [France] ; Alain Destée [France] ; Jacques Caron [France]Choreic movements induced by cibenzoline: An Ic class antiarrhythmic effect?
004D60 (1999) Elan D. Louis [États-Unis] ; Peter Lee [États-Unis] ; Lori Quinn [États-Unis] ; Karen Marder [États-Unis]Dystonia in Huntington's disease: Prevalence and clinical characteristics
004D62 (1999) Kiyoshi Negoro [Japon] ; Mitsunori Morimatsu [Japon] ; Hiroshi Nogaki [Japon]Drug‐induced dystonia and dysphonia in Parkinson's disease
005659 (1996) Tison [France] ; L. Wiart [France] ; M. Guatterie [France] ; N. Fouillet [France] ; V. Lozano [France] ; P. Henry [France] ; M. Barat [France]Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease
005660 (1996) L. Verhagen Metman [États-Unis] ; P. J. Blanchet [États-Unis] ; D. De Jong [États-Unis] ; M. M. Mouradian [États-Unis] ; Chase [États-Unis]Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease
005708 (1996) A. P. Sempere [Espagne] ; J. Duarte [Espagne] ; F. García [Espagne] ; C. Cabezas [Espagne] ; F. Coria [Espagne] ; L. E. Clavería [Espagne]An estimate of the risk of movement disorders associated with the chronic use of clebopride
005797 (1995) M. Macucci ; M T Dotti ; A. FedericoFamilial acute dystonic-dyskinetic syndrome with dominant inheritance after use of antidopaminergic antiemetic drugs.
005B02 (1994) Chris Van Der Linden [Belgique] ; Richard Bruggeman [Pays-Bas] ; Theo C. A. M. Van Woerkom [Pays-Bas]Serotonin‐dopamine antagonist and Gilles de la tourette's syndrome: An open pilot dose‐titration study with risperidone

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Dopamine Antagonists (adverse effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Dopamine Antagonists (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dopamine Antagonists (adverse effects)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024